Siegfried Capabilities Update October 2026: Small Molecule Drug Substance

Ensuring reliable supply of the most complex small molecules through a truly global network

As the leading global CDMO for small molecules, Siegfried combines deep scientific expertise, integrated development and manufacturing, and a global network of 10 small molecules manufacturing sites across the US, Europe and China. Our network provides flexible capacity, technology transfer and dual-supply options to strengthen security of supply. With 150+ years of experience and 1,600+ development projects, we bring deep expertise in complex chemistry, high-potency APIs and controlled substances. From pre-clinical development through commercial supply, our integrated capabilities enable seamless scale-up, preserve process knowledge and support reliable supply throughout the product lifecycle.

At Life Science Connect Outsourced Pharma – Capabilities Update: Small Molecule Drug Substance, we will illustrate how three strengths come together to deliver reliable supply:

• A truly global network across the US, Europe and China, providing flexible capacity, technology transfer and dual-supply options to strengthen security of supply.
• Deep scientific and process expertise, including advanced process chemistry and capabilities for complex, high-potency and controlled-substance APIs.
• Integrated capabilities from pre-clinical development to commercial manufacturing, enabling continuity of knowledge, efficient scale-up and reliable lifecycle support.

For customers, the value of a global CDMO network goes beyond geographic reach. It is the ability to combine the right expertise, technologies and capacity across sites, while maintaining the process knowledge and quality standards required to deliver consistently. It also provides flexibility as requirements change—from early clinical quantities and launch preparation to commercial growth, peak demand and mature-product supply.

By combining scientific depth, end-to-end capabilities and an integrated global manufacturing network, Siegfried helps customers turn complex small-molecule candidates into robust, scalable processes and, ultimately, reliable products for patients. Our goal is not simply to manufacture a product, but to provide customers with the confidence that they have a long-term partner and a global network designed to deliver reliable and secure supply from development through commercialization and beyond.